A Study to Compare Efficacy and Safety of Nanogen's Darbepoetin Alfa With Aranesp ® (Amgen) in the Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis (CKD).

Conditions:   Anemia;   Chronic Kidney Disease Requiring Chronic Dialysis Intervention:   Biological: Stimus (NNG-DEPO) Sponsors:   Nanogen Pharmaceutical Biotechnology Joint Stock Company;   Vietstar Biomedical Research;   MEDPHASE CLINICAL RESEARCH CONSULTANT COMPANY LIMITED;   CLINICAL RESEARCH VIET NAM SKILL TRAINING AND CONSULTING COMPANY LIMITED;   MedProve Inc Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials